Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
This is a 36 months, randomized, double-blind, placebo-controlled, parallel-groups,
equivalence multicenter trial in patients with inactive Systemic Lupus Erythematosus to
evaluate if low disease activity can be sustained with withdrawal of glucocorticoids in
patients on stable clinical remission or low disease activity.